Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,961
  • Shares Outstanding, K 15,184
  • Annual Sales, $ 40,740 K
  • Annual Income, $ -6,960 K
  • 60-Month Beta 0.14
  • Price/Sales 1.44
  • Price/Cash Flow 60.18
  • Price/Book 1.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -112.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.20 +1.90%
on 02/18/20
5.05 -15.25%
on 01/28/20
-0.72 (-14.40%)
since 01/24/20
3-Month
4.20 +1.90%
on 02/18/20
5.52 -22.46%
on 12/02/19
-0.50 (-10.53%)
since 11/25/19
52-Week
4.19 +2.21%
on 11/21/19
6.99 -38.77%
on 05/20/19
-1.28 (-23.02%)
since 02/25/19

Most Recent Stories

More News
Global N-acetylcysteine (CAS 616-91-1) Market to Boost Business Scope with Key Players BASF, WACKER, Cumberland Pharmaceuticals, Zambon

Get an extensive research offering detailed information and growth outlook of the in the new research report added by Big Market Research. The report presents a brief summary of the market by gathering...

CPIX : 4.25 (-3.63%)
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company with a focus on hospital acute care, today announced the launch of Caldolor® (ibuprofen) Injection in a ready-to-use...

CPIX : 4.25 (-3.63%)
Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will hold an update call to discuss recent developments and plans for the Company's Caldolor® and RediTrexTM brands after the market...

CPIX : 4.25 (-3.63%)
New Strong Sell Stocks for December 4th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

TRN : 21.38 (-2.06%)
ANIP : 57.52 (-2.06%)
CPIX : 4.25 (-3.63%)
LINC : 2.61 (+4.82%)
ADS : 95.08 (-3.69%)
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for RediTrex(TM), its...

CPIX : 4.25 (-3.63%)
New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company announces a new online publication in Drugs - Real World Outcomes, detailing the positive clinical outcomes that...

CPIX : 4.25 (-3.63%)
Cumberland: 3Q Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported a loss of $2 million in its third quarter.

CPIX : 4.25 (-3.63%)
Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today announced third quarter 2019 financial results with net revenues...

CPIX : 4.25 (-3.63%)
N-acetylcysteine (CAS 616-91-1) Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2025

The report provides rational insights along with historical and forecast data to aid in better understanding of the Global N-acetylcysteine (CAS 616-91-1) Market. The report provides a comprehensive analysis...

CPIX : 4.25 (-3.63%)
Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.56 in the latest trading session, marking a -0.18% move from the prior day.

CPIX : 4.25 (-3.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CPIX with:

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

2nd Resistance Point 4.58
1st Resistance Point 4.50
Last Price 4.25
1st Support Level 4.33
2nd Support Level 4.24

See More

52-Week High 6.99
Fibonacci 61.8% 5.92
Fibonacci 50% 5.59
Fibonacci 38.2% 5.26
Last Price 4.25
52-Week Low 4.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar